Cargando…

RNAs in Brain and Heart Diseases †

In the era of single-cell analysis, one always has to keep in mind the systemic nature of various diseases and how these diseases could be optimally studied. Comorbidities of the heart in neurological diseases as well as of the brain in cardiovascular diseases are prevalent, but how interactions in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beis, Dimitris, Zerr, Inga, Martelli, Fabio, Doehner, Wolfram, Devaux, Yvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279324/ https://www.ncbi.nlm.nih.gov/pubmed/32466222 http://dx.doi.org/10.3390/ijms21103717

Ejemplares similares

Ischemic stroke and heart failure: facts and numbers
por: Scherbakov, Nadja, et al.
Publicado: (2015)

Regulatory RNAs in Heart Failure
por: Gomes, Clarissa Pedrosa da Costa, et al.
Publicado: (2020)

Cachexia as a common characteristic in multiple chronic disease
por: Scherbakov, Nadja, et al.
Publicado: (2019)

Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease
por: Acharya, Shubhra, et al.
Publicado: (2020)

On Zebrafish Disease Models and Matters of the Heart
por: Giardoglou, Panagiota, et al.
Publicado: (2019)

Interdisciplinary stroke care in 2020: the need for cardiologists to learn about stroke
por: Doehner, Wolfram, et al.
Publicado: (2020)

Sarcopenia in stroke—facts and numbers on muscle loss accounting for disability after stroke
por: Scherbakov, Nadja, et al.
Publicado: (2011)

Do we need a reference standard for the muscle mass measurements?
por: Scherbakov, Nadja, et al.
Publicado: (2018)

Dementia and the heart failure patient
por: Doehner, Wolfram
Publicado: (2019)

The obesity paradox in chronic disease: facts and numbers
por: Lainscak, Mitja, et al.
Publicado: (2012)

Noncoding RNAs in Hypertension
por: Jusic, Amela, et al.
Publicado: (2019)

Ischemic Stroke and Heart Failure: Facts and Numbers. An Update
por: Barkhudaryan, Anush, et al.
Publicado: (2021)

Non-coding RNAs and stem cells: the dream team for neural regeneration in Parkinson’s disease?
por: Acharya, Shubhra, et al.
Publicado: (2021)

Comment on ‘Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetes’ by Niedziela et al.
por: Scherbakov, Nadja, et al.
Publicado: (2020)

Progress in CSF biomarker discovery in sCJD
por: Llorens, Franc, et al.
Publicado: (2016)

Integration of epigenetic regulatory mechanisms in heart failure
por: Sopic, Miron, et al.
Publicado: (2023)

Cachexia in heart disease: highlights from the ESC 2010
por: Kung, Thomas, et al.
Publicado: (2011)

Iron deficiency in chronic heart failure: case‐based practical guidance
por: Lam, Carolyn S. P., et al.
Publicado: (2018)

Human prion diseases: progress in clinical trials
por: Zerr, Inga
Publicado: (2013)

Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era
por: Greco, S., et al.
Publicado: (2020)

CircRNAs in the heart: bricks in Brunelleschi’s Dome
por: De Majo, Federica, et al.
Publicado: (2020)

Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection †
por: Kura, Branislav, et al.
Publicado: (2020)

Diagnostic performance of microRNAs in the detection of heart failure with reduced or preserved ejection fraction: a systematic review and meta‐analysis
por: Parvan, Reza, et al.
Publicado: (2022)

When a reference value makes all the difference
por: Doehner, Wolfram
Publicado: (2012)

In Full Force. Mechanotransduction and Morphogenesis during Homeostasis and Tissue Regeneration
por: Tsata, Vasiliki, et al.
Publicado: (2020)

Trimethylamine-N-oxide is an important target for heart and brain diseases
por: Ding, Shusi, et al.
Publicado: (2022)

A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin
por: Younas, Neelam, et al.
Publicado: (2022)

Circular RNAs in the cardiovascular system
por: Gomes, Clarissa P.C., et al.
Publicado: (2018)

Circulating microRNAs and Outcome in Patients with Acute Heart Failure
por: Seronde, Marie-France, et al.
Publicado: (2015)

Circular RNAs in Muscle Function and Disease
por: Greco, Simona, et al.
Publicado: (2018)

Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network
por: Azuaje, Francisco, et al.
Publicado: (2010)

Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany
por: Theidel, Ulrike, et al.
Publicado: (2017)

A Machine Learning Model Based on microRNAs for the Diagnosis of Essential Hypertension
por: Jusic, Amela, et al.
Publicado: (2023)

Proenkephalin A as Potential Prognostic Biomarker in Acute Ischemic Stroke
por: Shafieesabet, Azadeh, et al.
Publicado: (2020)

Comment on: “Handgrip weakness, low fat‐free mass, and overall survival in nonsmall cell lung cancer treated with curative‐intent radiotherapy" by Burtin et al.
por: Shafieesabet, Azadeh, et al.
Publicado: (2020)

Comment on: “Experimental ischaemic stroke induces transient cardiac athrophy” by Veltkamp et al.
por: Scherbakov, Nadja, et al.
Publicado: (2020)

Searching for a relevant definition of sarcopenia: results from the cross‐sectional EPIDOS study
por: Scherbakov, Nadja, et al.
Publicado: (2015)

A Year in the Life of the EU-CardioRNA COST Action: CA17129 Catalysing Transcriptomics Research in Cardiovascular Disease
por: Robinson, Emma Louise, et al.
Publicado: (2020)

Oxidative Stress and MicroRNAs in Vascular Diseases
por: Magenta, Alessandra, et al.
Publicado: (2013)

Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems
por: Spinetti, Gaia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f69o6ug9ofp6hserfr4o05eenk